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Experts from the World Health Organization
(WHO), the European Union (EU), the U.S.
Department of Defense (DoD), and other
organizations summarized existing and planned
collaborations on emerging infectious diseases.
The session was chaired by David Heymann,
WHO, and James LeDuc, CDC.
One speaker, V. Ramalingaswami, All India
Institute of Medical Sciences, India, summarized
lessons learned from the plague outbreak in
Surat, India. The plague outbreak, the first in
many years, found the country ill-prepared to
diagnose this disease, and young clinicians
lacked experience in recognizing or managing
plague-infected patients.
Two speakers examined regional collabora-
tions. Christopher Bartlett, Public Health
Laboratory Service, London, summarized the
development of international surveillance within
EU. The Maastricht Treaty provided the political
will to underpin these activities; since the treaty,
the heads of European institutes with responsi-
bility for national surveillance have met
regularly to assist in strategic development of
surveillance activities. Disease-specific networks
have been established, each with an operational
protocol that sets out agreed case definitions and
standard methods and use of information
obtained. High quality and timely information is
now being provided on a steadily increasing
spectrum of infectious diseases through weekly
electronic and monthly surveillance bulletin
publications. Oyewale Tomori, regional virologist
for Africa from WHO, explained that despite
substantial advances in disease prevention and
control, communicable diseases still constitute a
major health problem for Africa. Concern about
the deplorable and worsening state of disease
control in Africa has led ministers of health in the
region to pass several resolutions on prevention
of epidemic infectious diseases, yet frequent
epidemics continue. Apart from the development
of a few disease-specific laboratory diagnostic
networks, laboratory services in Africa remain
rudimentary and underdeveloped. The WHO
Regional Office for Africa has recently formu-
lated a strategic plan for integrated disease
surveillance and an action plan to strengthen
laboratory capacity in Africa; international
support is urgently needed to implement these
plans.
Global collaborations were also discussed.
Nils Daulaire, U.S. Agency for International
Development (USAID), described the recently
announced $50 million initiative to address
infectious diseases globally. These funds will be
used to focus activities on tuberculosis, malaria,
antimicrobial resistance, and surveillance, both
in countries with USAID missions, as well as
regionally. Michael McCarthy, DoD, summarized
the new DoD initiative on emerging infectious
diseases and explained how the overseas
laboratories in Thailand, Kenya, Peru, Brazil,
Egypt, and Indonesia will work closely with their
host nations and DoD scientists to address
emerging endemic disease threats. Maria Neira,
WHO, described recent activities to address
cholera and other diarrheal diseases of epidemic
potential globally. These activities included the
secondment of a CDC medical epidemiologist to the
WHO subregional office for southern Africa, where
in the past several years a plan to improve
recognition and response to epidemic diarrheal
diseases has been developed and implemented.
Included in the program are training on improved
patient management, strengthened laboratory
capacity, and better communication both within
and between countries of southern Africa.
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